Active drain vs passive drain
It is very uncertain whether active drain changes length of hospital stay compared with passive drain following pancreatic surgery (very low certainty).
- no estimate extracted2 studies · 321 participantsVery low
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
It is very uncertain whether active drain changes length of hospital stay compared with passive drain following pancreatic surgery (very low certainty).
It is very uncertain whether early changes mortality compared with late drain removal following pancreatic surgery (very low certainty).
It is very uncertain whether early changes intra‐abdominal infection compared with late drain removal following pancreatic surgery (very low certainty).
It is very uncertain whether early changes wound infection compared with late drain removal following pancreatic surgery (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether early changes morbidity compared with late drain removal following pancreatic surgery (very low certainty).
It is very uncertain whether early changes length of hospital stay compared with late drain removal following pancreatic surgery (very low certainty).
It is very uncertain whether drain use changes intra‐abdominal infection compared with no drain use following pancreatic surgery (very low certainty).
Drain use showed no clear difference in wound infection compared with no drain use following pancreatic surgery (low certainty).
Drain use showed no clear difference in morbidity compared with no drain use following pancreatic surgery (moderate certainty).
Drain use showed no clear difference in length of hospital stay compared with no drain use following pancreatic surgery (low certainty).
It is very uncertain whether active drain changes mortality compared with passive drain following pancreatic surgery (very low certainty).
It is very uncertain whether autologous blood or PRP changes treatment success (> 25% improvement in pain or function) compared with placebo at 3 months' follow‐up (very low certainty).
It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events  compared with placebo at 3 months' follow‐up (very low certainty).
The review found no eligible studies for this question.